BREAST is a leading peer-reviewed journal dedicated to advancing knowledge and practice in the fields of cancer research, oncology, and surgery, published by Churchill Livingstone. With an impressive impact factor and a prestigious Q1 ranking in multiple categories including Cancer Research, Medicine, and Surgery, the journal consistently delivers high-quality content that informs and inspires researchers, clinicians, and educators. Since its transition to Open Access in 2020, BREAST has significantly expanded its reach, providing immediate and unrestricted access to pivotal studies and findings in breast health and disease management. With a history dating back to 1992 and converging to 2024, the journal serves as an essential resource for the latest developments and innovative approaches in the clinical and biomedical aspects of breast care. Scholars and professionals alike can explore a wealth of research aimed at improving patient outcomes and fostering scientific dialogue in this vital area of healthcare.

JOURNAL OF ENDOUROLOGY, published by Mary Ann Liebert, Inc, stands as a premier periodical in the fields of urology and medicine, dedicated to the dissemination of cutting-edge research and innovative approaches in endourology. With a notable impact factor reflecting its stature—ranking #17 out of 120 in Urology and placing in the 86th percentile according to Scopus—this journal is pivotal for professionals, researchers, and students alike who seek to stay at the forefront of advancements in patient care and surgical techniques. Established in 1987 and continuing its legacy into 2024, the journal serves an essential role in bridging scientific discovery and clinical practice through its commitment to rigorous peer-review and high-quality publications. Although it does not offer open access, the JOURNAL OF ENDOUROLOGY remains an indispensable resource for those passionate about the evolving landscape of urological health.

Surgical Oncology-Oxford is a prestigious academic journal published by Elsevier Science Ltd, dedicated to advancing the field of surgical oncology. Since its establishment in 1992, the journal has provided a vital platform for disseminating cutting-edge research, clinical advancements, and innovative surgical techniques. With a focus on both surgery and oncology, the journal is ranked in the Q2 category in Surgery and Q3 in Oncology for 2023, reflecting its commitment to quality and impactful contributions. It ranks #107 out of 551 in Medicine_Surgery and #184 out of 404 in Medicine_Oncology as per Scopus metrics, illustrating its significant role in the academic landscape. Although it does not currently offer open access options, the journal's rigorous peer-review process ensures that only the highest quality research is published. By examining the latest surgical methodologies and oncological insights, Surgical Oncology-Oxford plays a crucial role in enhancing clinical practice and improving patient outcomes, making it an essential resource for researchers, healthcare professionals, and students aiming to stay at the forefront of the field.

Minerva Urology and Nephrology is a prestigious journal published by EDIZIONI MINERVA MEDICA, focusing on the rapidly evolving fields of urology and nephrology. Since its inception in 2021, this journal has established itself as a leading platform for innovative research, evidenced by its impressive Q1 quartile ranking in both nephrology and urology for the year 2023. With an ISSN of 2724-6051 and an E-ISSN of 2724-6442, it provides a rigorous peer-review process and publishes cutting-edge studies that push the boundaries of current understanding and clinical practice. Although currently not open access, Minerva Urology and Nephrology aims to facilitate knowledge sharing among researchers, healthcare professionals, and students who are engaged in these critical areas of medicine. This journal’s commitment to quality and relevance positions it as an essential resource for anyone interested in advancing their knowledge and skills in urology and nephrology.

OTOLARYNGOLOGY-HEAD AND NECK SURGERY, published by Wiley, stands as a premier journal in the fields of otorhinolaryngology and surgery, boasting an impressive impact ranking in the 95th percentile among its peers. With an ISSN of 0194-5998 and E-ISSN 1097-6817, this journal has been a cornerstone for researchers and clinicians since its inception in 1978, continuing its valuable contributions to 2024. Notably, it holds a Q1 category ranking in both Otorhinolaryngology and Surgery, exemplifying its influence and the high caliber of research it publishes. As it garners significant attention in the scientific community, researchers are encouraged to delve into its articles for comprehensive insights into advanced surgical techniques and emerging trends in head and neck medicine. Access to its extensive repository of research is available through traditional subscription models, allowing professionals and students alike to benefit from the wealth of knowledge at their fingertips.

Surgery in Practice and Science is a prominent academic journal published by Elsevier, focusing on the interdisciplinary fields of Otorhinolaryngology, Surgery, and Urology. With an ISSN of 2666-2620 and existing as an Open Access publication since 2020, this journal aims to facilitate widespread dissemination of vital research findings to enhance clinical practices and improve patient outcomes. Operating from the United Kingdom, this journal has established its place within the academic community, achieving a Q3 quartile ranking in 2023 across its respective categories, which reflects its commitment to quality and relevance in contemporary surgical discussions. Although the H-index is currently not specified, Surgery in Practice and Science has garnered recognition through its respective Scopus rankings, positioning it as a valuable resource for researchers, professionals, and students. With its objective of promoting knowledge exchange and innovation in surgical techniques and methodologies, this journal continues to play an essential role in its field, paving the way for future advancements in surgery and allied disciplines.

Indian Journal of Urology, published by Wolters Kluwer Medknow Publications, is a premier open-access journal dedicated to the field of urology, serving as a vital platform for researchers and clinicians to disseminate groundbreaking findings since its inception in 2001. With an ISSN of 0970-1591 and an E-ISSN of 1998-3824, this journal has established itself as a crucial resource for advancing knowledge in urological practices, particularly within the Indian context. Recognized in the 2023 Scopus Rankings with a classification of Q3 in Urology, it stands at a significant position (Rank #71 out of 120) with a 41st percentile performance, highlighting its role in contributing to the global discourse in urological medicine. The journal provides open access options, ensuring that high-quality research is readily available to a broad audience, fostering collaboration and innovation. Publishing significant studies from various converged years, including from 1984 to 1999 and more recently from 2006 to 2024, Indian Journal of Urology is essential for professionals seeking to stay updated with the latest advances and best practices in urology.

Urologia Journal, with ISSN 0391-5603 and E-ISSN 1724-6075, is a pivotal publication in the field of urology, published by SAGE Publications Ltd. Established in the United States, the journal has a rich historical foundation, with coverage spanning various periods beginning in 1947 and continuing to the present day, indicating its commitment to chronicling advancements in urological research and practice. As of 2023, the journal has achieved a respectable Q3 ranking in the field of Urology, reflecting its increasing influence and relevance among academic peers. Though not an open-access journal, it provides substantial value to its readers with rigorous peer-reviewed content that enhances the understanding and treatment of urological conditions. Researchers, clinicians, and students are encouraged to engage with the Urologia Journal to keep abreast of the latest findings and methodologies that contribute to better patient care and innovative therapeutic options in urology. As the field evolves, Urologia Journal remains committed to promoting quality scholarship and disseminating vital knowledge that shapes the future of urology.

Welcome to the Turk Gogus Kalp Damar Cerrahisi Dergisi (Turkish Journal of Thoracic and Cardiovascular Surgery), a distinguished publication focused on advancing the fields of cardiovascular and thoracic surgery. Published by BAYCINAR MEDICAL PUBL, this journal plays a crucial role in disseminating high-quality research and clinical findings from Turkey and beyond. With an ISSN of 1301-5680, the journal covers interdisciplinary topics while holding a respectable Q3 ranking in Surgery and Q4 rankings in both Cardiology and Pulmonary Medicine as of 2023. Although it currently operates on a subscription basis, researchers and practitioners can access vital insights that drive innovation and improve patient outcomes in cardiovascular care. Established to foster knowledge sharing among professionals and scholars, the journal is essential for anyone involved in the cardiovascular and thoracic surgery landscape. With a commitment to high standards and scholarly excellence, the Turk Gogus Kalp Damar Cerrahisi Dergisi invites you to explore the latest research that shapes the future of patient care.

European Urology Oncology is a premier academic journal dedicated to advancing the field of urological oncology through innovative research and interdisciplinary collaboration. Published by Elsevier and based in the Netherlands, this journal runs on the principles of providing high-quality, peer-reviewed content that meets the evolving needs of professionals in medicine, surgery, and oncology. With an impressive 2023 categorization in the Q1 quartiles across multiple disciplines including Medicine (Miscellaneous), Oncology, and Urology, the journal demonstrates its pivotal role in disseminating essential findings that enhance clinical practices. The E-ISSN of this journal is 2588-9311, ensuring accessibility to groundbreaking articles that influence treatment methodologies and patient outcomes. Researchers and professionals relying on the latest evidence in urology and oncology will find this journal essential for keeping abreast of cutting-edge developments and clinical insights that shape the future of healthcare.